0001644338-21-000003.txt : 20210325 0001644338-21-000003.hdr.sgml : 20210325 20210325160723 ACCESSION NUMBER: 0001644338-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210325 DATE AS OF CHANGE: 20210325 EFFECTIVENESS DATE: 20210325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vigeo Therapeutics, Inc. CENTRAL INDEX KEY: 0001644338 IRS NUMBER: 461204256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-393558 FILM NUMBER: 21772427 BUSINESS ADDRESS: STREET 1: 50 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-571-6800 MAIL ADDRESS: STREET 1: 50 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001644338 Vigeo Therapeutics, Inc. 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 617-571-6800 DELAWARE None None Corporation true Jing Watnick 86 Sherman Strefet Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Peter B. Finn 53 State Street Boston MA MASSACHUSETTS 02109 Executive Officer James E. Mahoney 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 Director Westerly Nolin, Ph.D. 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 Director Stephanie O'Brien 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 Director Biotechnology Decline to Disclose 06b false 2021-03-15 false true false 7500000 17500000 7500000 10000000 false 1 0 0 0 false Vigeo Therapeutics, Inc. PETER B. FINN PETER B FINN SECRETARY 2021-03-25